Purple Biotech (PPBT) Interest & Investment Income (2014 - 2026)
Purple Biotech's (PPBT) quarterly Interest & Investment Income came in at -$20000.0 in Q1 2026, up 62.96% year-on-year from -$12272.7 in Q1 2025, and up 74.68% on a QoQ basis from -$79000.0 in Q4 2025.
Purple Biotech (PPBT) Interest & Investment Income (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of Interest & Investment Income data on file, last reported at -$20000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 62.96% year-over-year to -$20000.0 in Q1 2026; TTM through Mar 2026 was -$295000.0, a 61.24% increase from a year earlier, with the FY2025 full-year figure at $424000.0, down 51.15% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$20000.0, up from -$79000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for PPBT reached as high as $2.1 million in Q4 2023 and fell as low as -$708000.0 in Q3 2023.
- Historically, Interest & Investment Income has averaged -$66352.9 across 5 years, with a median of -$121000.0 in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 464.76% in 2023 and fell as far as 396.43% in 2023.
- Year by year, Interest & Investment Income stood at -$576000.0 in 2022, then surged by 464.76% to $2.1 million in 2023, then slumped by 121.7% to -$456000.0 in 2024, then jumped by 82.68% to -$79000.0 in 2025, then surged by 74.68% to -$20000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$20000.0 in Q1 2026, -$79000.0 in Q4 2025, and -$123000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Purple Biotech | 1.31 Bn | 1.31 Bn | - | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | -79,000.00 |
| Sep 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -73,000.00 |
| Mar 31, 2025 | -54,000.00 |
| Dec 31, 2024 | -456,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -121,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | -708,000.00 |
| Jun 30, 2023 | -123,000.00 |
| Mar 31, 2023 | -278,000.00 |
| Dec 31, 2022 | -576,000.00 |
| Sep 30, 2022 | -248,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -124,000.00 |
| Sep 30, 2021 | -68,000.00 |
| Jun 30, 2021 | -78,000.00 |